Premier Alternatives

Centaur.ai

Enterprise Systems (Healthcare) · Boston, MA · Founded 2017 · Privately Held (backing)

Provider of medical data annotation services intended to offer assistance with medical decisions and diagnosis. Centaur.ai is based in Boston, MA and was founded in 2017. Its last known valuation is $70.4 million. It has raised $32 million across 2 recorded rounds; the latest was a $16 million Series B in Oct 2024.

Last price · $/share
—
Implied valuation
$70.4M
Total raised
$32.0M
Last round
Later Stage VC (Series B)
Oct 2024

Centaur.ai key facts

  • Provider of medical data annotation services intended to offer assistance with medical decisions and diagnosis.
  • Centaur.ai’s last known valuation is $70.4M.
  • It has raised $32.0M across 2 recorded rounds; the latest was Later Stage VC (Series B) ($16.0M) in Oct 2024.
  • Notable investors include Y Combinator, Alumni Ventures, Accel, Matrix, Global Founders Capital — 30 tracked in total.
  • Status: Privately Held (backing).
Free account
More of Centaur.ai with a free account
  • ·The complete investor list: 30 names
  • ·Watch Centaur.ai: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Centaur.ai funding rounds

2 rounds
Oct 2024Later Stage VC (Series B)$16.0M▮
Aug 2021Early Stage VC (Series A)$15.9M▮
Full funding history →

Centaur.ai valuation

Centaur.ai's last known valuation is $70.4 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Centaur.ai raised?

Centaur.ai has raised $32 million across 2 recorded rounds since 2021. The largest was a $16 million Series B in Oct 2024.

Centaur.ai investors

30 investors are on record for Centaur.ai, including Y Combinator, Alumni Ventures, Accel and Matrix. By type, the record holds 12 venture capital firms and 1 angel investor. The Series B in Oct 2024 drew 11 investors.

Comparable companies

Comparable enterprise systems (healthcare) names by valuation on PrivateMarketView: Clarify (Dover) ($77 million), Plenful ($68 million) and ThoroughCare ($53 million).

About Centaur.ai

Provider of medical data annotation services intended to offer assistance with medical decisions and diagnosis. The company's platform offers medical decision-making through medical data labeling and analyzes medical cases as they help to build the next generation of medical AI, enabling patients to reduce costs and have improved healthcare outcomes.

Industry
Enterprise Systems (Healthcare)
Sector
Healthcare
HQ
Boston, MA, United States
Founded
2017
Employees
34
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$70.4M

Centaur.ai’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.